Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

3yrs ago Cannabis marijuanalawyerblog Views: 457

The U.S. Drug Enforcement Administration (DEA) released a new interim rule on hemp and derivative products, such as CBD. The DEA insists that this final rule simply conforms the agency’s regulations to the statutory changes made to the Controlled Substances Act in the 2018 Farm Bill. -

But our Los Angeles CBD lawyers know that those in the hemp processing business still need to use special care. The 2018 Farm Bill did in fact legalize hemp, its derivatives and extracts. Yet nothing in the bill expressly covers processing of hemp, and the new DEA regulations don’t address it either. This creates some concern that hemp processing companies may face criminal actions because the chemical effect of the hemp extraction process can push the THC concentration above the legal limit.

Hemp production is regulated by the U.S. Food and Drug Administration, which requires the plant to be tested for THC content before it’s harvested. But the USDA doesn’t oversee hemp processing. Some state governments do regulate hemp processing, issuing licenses and implementing certain standards. In California, Cal. Food and Agric. Code §81000 to 81010 allows for a commercial hemp program that’s overseen by the Industrial Hemp Advisory Board, a subsidiary within the state’s Department of Food and Agriculture. There is also a registration for seed breeders.

The fact that the 2018 federal law glosses over hemp processing is important to understanding why the DEA’s interim rule is inconsistent and raises some red flags.

The Farm Bill defined hemp as a cannabis plant with a THC concentration of less than 0.3 percent based on dry weight. The statute also recognizes extracts, derivatives and hemp cannabinoids as being legal. Logically, that would lead one to think it’s lawful to process them. However, the DEA rule does not. What it fails to consider is that creating derivative hemp products requires a process called extraction. Extraction inevitably increases the amount of THC, at least temporarily. There’s virtually no way to control this until it can be diluted to the required levels. What this means is that at least during part of the extraction process, hemp production businesses would be in possession of a Schedule I narcotic.

If the DEA were only stipulating that the end product couldn’t have more than 0.3 percent THC, that wouldn’t be cause for much concern. And the 2018 Farm Bill expressly states that derivatives and extracts of hemp are to be removed from the Controlled Substances Act. But the process of turning hemp into extracts inevitably results in a higher level of THC, which in turn means that either deliberately or unintentionally, hemp processing companies could find themselves in violation of the law. If the DEA chooses to pursue criminal charges against hemp processing companies, this regulatory gap may give them the authority to do that.

Because this is an interim rule, effective Aug. 21st, the DEA allows submission of public comment until Oct. 20. Still, it is considered the law until it expires, is amended or made permanent.

Our hemp and CBD lawyers in Los Angeles will continue to monitor this situation, and are prepared to help any hemp processing companies fight criminal charges, should they arise.

The Los Angeles CANNABIS LAW Group represents growers, dispensaries, ancillary companies, patients, doctors and those facing marijuana charges. Call us at 714-937-2050.

Additional Resources:

DEA Proposes Hemp And CBD Rules To Comply With Crop’s Legalization, Aug. 20, 2020, By Kyle Jaeger, Marijuana Moment


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.